Initiation Of Phase I Combination Clinical Trial Of Brentuximab Vedotin SGN-35 For Front-Line Hodgkin Lymphoma

Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Source: General Cancer News Articles Provided by Cancer Compass

Multiple Myeloma Research Consortium MMRC Initiates Phase Ib/II Clinical Trial Of Treanda In Combination With Revlimid And Dexamethasone In Patients With Relapsed Multiple Myeloma
Journal Of Clinical Oncology Publishes Data On Overall Survival Benefit Of VELCADE Bortezomib For Injection In Patients With Previously Untreated Multiple Myeloma
Researchers' Work From Academic Medical Center, Department Of Hematology Focuses On Non-Hodgkin Lymphoma
ArQule Announces Initiation of Clinical Programs with ARQ 197 in Germ Cell Tumors and Colorectal Cancer
Celldex Therapeutics Announces Initiation Of Randomized Phase 2 Clinical Trial Of CDX-1307 In Front Line Bladder Cancer
Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer
Lifestyle Factors Significantly Impact Survival Of Non-Hodgkin's Lymphoma Patients, Study Finds
Merrimack Pharmaceuticals Initiates Enrollment In A Phase 1/2 Combination Study Of MM-121 And Tarceva In Patients With Non-Small Cell Lung Cancer
GTx Announces Top Line Results Of Phase III Clinical Trial Evaluating Toremifene 20 mg For The Prevention Of Prostate Cancer In Men With High Grade PIN
OSI Pharmaceuticals Announces That RADIANT, An International Phase III Tarceva Adjuvant Trial In Non-Small Cell Lung Cancer, Completes Enrollment
Human Genome Sciences Announces Results Of Randomized Phase 2 Trial Of Mapatumumab In Non-Small Cell Lung Cancer
Committee Recommends Continuation Of Phase III Study Of StemEx For Leukemia And Lymphoma
Late-Stage Ovarian Cancer Shows Promise In Two-Drug Phase I Trial
Telormedix' TMX-101 Commences Clinical Trial For Bladder Cancer
Synta Announces Positive Results In Phase 2 NSCLC Trial For STA-9090 Support Advancing Trial To Second Stage

Tags: Brentuximab, Clinical, Combination, FrontLine, Hodgkin, Initiation, Lymphoma, Phase, SGN35, Trial, Vedotin
Posted in Cancer on | There are currently No Comments

Cancer Cure Books

Sponsored Links

Initiation Of Phase I Combination Clinical Trial Of Brentuximab Vedotin SGN-35 For Front-Line Hodgkin Lymphoma

Related Posts:

Leave a Reply